Related Experiment Video
Updated: Jul 16, 2025

Author Spotlight: Enhancing Transplantation Research Through MicroCT Angiography in Murine Models
Published on: September 22, 2023
Screening Modalities for Coronary Artery Disease in Liver Transplant Candidates: A Review of the Literature
Cerise Kleb1, Omar T Sims2, Maan Fares3
1Department of Gastroenterology, University of Maryland Medical Center, Baltimore, MD.
Insights
Identifying coronary artery disease (CAD) in liver transplant (LT) candidates is crucial for post-transplant survival. This review evaluates various screening methods for CAD in LT candidates, considering their unique physiological challenges.
Area of Science:
- Cardiology
- Hepatology
- Transplant Surgery
Background:
- Liver transplant (LT) candidates with cirrhosis face high risks of cardiopulmonary complications.
- Coronary artery disease (CAD) significantly increases morbidity and mortality rates in post-LT patients.
- Accurate CAD screening is vital for optimizing survival in LT candidates.
Purpose of the Study:
- To review and describe various screening modalities for CAD in LT candidates.
- To discuss the background, diagnostic accuracy, and limitations of each screening method.
Main Methods:
- Literature review of current screening tests for CAD in LT candidates.
- Analysis of diagnostic accuracy and limitations specific to patients with cirrhosis.
- Evaluation of traditional vs. novel screening approaches.
Main Results:
- Consensus on the optimal CAD screening test for LT candidates is lacking.
- Traditional exercise and pharmacologic stress tests are often impractical and inaccurate in cirrhotic patients.
- The review details the utility and drawbacks of different diagnostic modalities.
Conclusions:
- Effective CAD screening is essential for improving outcomes in LT recipients.
- Further research may be needed to establish definitive guidelines for CAD screening in this population.
- Understanding the limitations of current tests is key to selecting appropriate screening strategies.
Abstract:
Patients with cirrhosis undergoing liver transplant (LT) are at high risk of postoperative cardiopulmonary complications. It is known that patients with coronary artery disease (CAD) have greater rates of post-LT morbidity and mortality than patients without CAD. Thus, identifying significant CAD in LT candidates is of the utmost importance to optimize survival posttransplant. Consensus is lacking on the ideal screening test for CAD in LT candidates. Traditional exercise and many pharmacologic stress tests are impractical and inaccurate in patients with cirrhosis due to their unique physiology. The purpose of this review is to describe different screening modalities for CAD among LT candidates. The background, diagnostic accuracy, and limitations of each screening modality are described to achieve this goal.
More Related Videos
Related Concept Videos
Kidney Transplant I: Introduction
Imaging Studies for Cardiovascular System V: CT
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Coronary Artery Disease V: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies

